disease Archivi - Pagina 3 di 7

Agenparl English

Neuroscientists identify cells especially vulnerable to Alzheimer’s

By Redazione19 Aprile 2023

(AGENPARL) – MASSACHUSETTS AVE CAMBRIDGE (USA) mer 19 aprile 2023 Neurodegeneration, or the gradual loss of neuron function, is one of…

Agenparl English

H.R. 2213 (IH) – To provide for a limitation on availability of funds for Related Agencies, Agency for Toxic Substances and Disease Registry, Toxic Substances and Environmental Public Health for fiscal year 2024.

By Redazione19 Aprile 2023

(AGENPARL) – WASHINGTON mer 19 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Agenparl English

H.R. 1980 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Disease for fiscal year 2024.

By Redazione19 Aprile 2023

(AGENPARL) – WASHINGTON mer 19 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Agenparl English

Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

By Redazione18 Aprile 2023

(AGENPARL) – SILVER SPRING mar 18 aprile 2023 Lyme disease is on the rise. How can you prevent it? What are…

Agenparl English

Rare Disease Endpoint Advancement Pilot Program

By Redazione17 Aprile 2023

(AGENPARL) – SILVER SPRING lun 17 aprile 2023 FDA is establishing a Rare Disease Endpoint Advancement (RDEA) Pilot Program to support…

Agenparl English

FDA CDER and CBER & Duke-Margolis Center for Health Policy | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development – 06/07/2023

By Redazione17 Aprile 2023

(AGENPARL) – SILVER SPRING lun 17 aprile 2023 The purpose of this public workshop is to discuss topics relevant to the…

Agenparl English

H.R. 1964 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Chronic Disease Prevention and Health Promotion for fiscal year 2024.

By Redazione15 Aprile 2023

(AGENPARL) – WASHINGTON sab 15 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Agenparl English

H.R. 1974 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention-Wide Activities and Program Support for fiscal year 2024.

By Redazione15 Aprile 2023

(AGENPARL) – WASHINGTON sab 15 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Agenparl English

H.R. 1967 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Environmental Health for fiscal year 2024.

By Redazione15 Aprile 2023

(AGENPARL) – WASHINGTON sab 15 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Agenparl English

H.R. 1966 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Public Health Scientific Studies for fiscal year 2024.

By Redazione15 Aprile 2023

(AGENPARL) – WASHINGTON sab 15 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…

Browsing: disease

Neuroscientists identify cells especially vulnerable to Alzheimer’s

H.R. 2213 (IH) – To provide for a limitation on availability of funds for Related Agencies, Agency for Toxic Substances and Disease Registry, Toxic Substances and Environmental Public Health for fiscal year 2024.

H.R. 1980 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Disease for fiscal year 2024.

Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

Rare Disease Endpoint Advancement Pilot Program

FDA CDER and CBER & Duke-Margolis Center for Health Policy | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development – 06/07/2023

H.R. 1964 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Chronic Disease Prevention and Health Promotion for fiscal year 2024.

H.R. 1974 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention-Wide Activities and Program Support for fiscal year 2024.

H.R. 1967 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Environmental Health for fiscal year 2024.

H.R. 1966 (IH) – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Public Health Scientific Studies for fiscal year 2024.

CHI SIAMO

CONTATTI

Per inviare i comunicati stampa:

redazione@agenparl.eu

Per informazioni:

marketing@agenparl.eu

Uff. (+39) 06 93 57 9408

Cell. (+39) 340 681 9270

SERVIZI

Agenparl dispone di contenuti, servizi e strumenti a cui si affidano Enti, Istituzioni ed Università, sviluppando una serie di soluzioni personalizzabili a seconda delle necessità dei clienti.

Per tutti i servizi scrivere a
marketing@agenparl.eu

© Tutti i diritti e contenuti sono di Agenparl

Browsing: disease

CHI SIAMO

CONTATTI

Per inviare i comunicati stampa:

redazione@agenparl.eu

Per informazioni:

marketing@agenparl.eu

Uff. (+39) 06 93 57 9408

Cell. (+39) 340 681 9270

SERVIZI

Agenparl dispone di contenuti, servizi e strumenti a cui si affidano Enti, Istituzioni ed Università, sviluppando una serie di soluzioni personalizzabili a seconda delle necessità dei clienti.

Per tutti i servizi scrivere amarketing@agenparl.eu

© Tutti i diritti e contenuti sono di Agenparl

Per tutti i servizi scrivere a
marketing@agenparl.eu